P2.12. Real-World Data of Biomarker Diagnostics, Treatment Strategy, and Survival Outcome with Advanced or Recurrent NSCLC in Japan - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Takaaki Tokito
Meta Tag
Speaker Takaaki Tokito
Topic Metastatic NSCLC: Targeted Therapy - Other
Biomarker Diagnostics
Treatment Strategy
Survival Outcome
Biomarker Testing
Concordance Rates
Targeted Therapy
Overall Survival
Multi-Gene Testing
Powered By